Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
08/2001
08/14/2001US6274636 Method for treating a tic disorder
08/14/2001US6274587 Tricyclic dihydropyrimidine potassium channel openers
08/09/2001WO2001057037A1 Platelet adp receptor inhibitors
08/08/2001EP1122254A2 4-Sulfonamide piperidine derivatives, method for their preparation and phamaceutical compositions containing them
08/08/2001EP1121342A1 Diaminopropionic acid derivatives
08/08/2001CN1069309C N-(aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphtalene-2-carboxamide derivative, preparation and application thereof
08/07/2001US6271235 HIV protease inhibitors
08/07/2001US6271225 Fused thiophene compounds and medicinal use thereof
08/01/2001EP1119571A2 Tricyclic delta3-piperidines as alpha2-antagonists
08/01/2001EP1119570A1 Tricyclic delta3-piperidines as pharmaceuticals
08/01/2001EP1119559A1 3-phenyl-pyrones
08/01/2001EP1119548A1 Pyrrole-2,5-diones as gsk-3 inhibitors
08/01/2001EP1119359A1 2-methyl-thieno-benzodiazepine formulation
08/01/2001CN1306535A Thienopyridine compounds, their prodn. and use
08/01/2001CN1306534A Thienopyrimidines
08/01/2001CN1306524A Fluorophenyl resin compounds
08/01/2001CN1306510A Optical active tetrahydrobenzindole derivatives
07/2001
07/31/2001US6268392 Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
07/31/2001US6268370 Compounds
07/31/2001US6268308 Herbicidal S-substituted 1,2,4,6-thiatriazines
07/31/2001CA2059305C Hexa-cyclic compound
07/31/2001CA2016908C Excitatory amino acid antagonists
07/26/2001WO2001053286A1 Di(het)arylaminothiophene derivatives
07/26/2001DE10002424A1 New 3,4-substituted 2-N,N-di(het)arylamino-thiophene derivatives, used in organic light-emitting diodes and organic photovoltaic components
07/25/2001EP1117667A1 BENZOTHIENO[3,2-c]PYRIDINES AS ALPHA2 ANTAGONISTS
07/25/2001EP1117656A1 Grey colouring photochromic fused pyrans
07/25/2001EP0885391A4 Method of detection of influenza virus and compounds for use therein
07/25/2001EP0783501B9 pyrimidone derivatives with antifungal activity
07/25/2001CN1305483A Polymorphic clopidogrel hydrogenesulphate form
07/25/2001CN1304930A Arylsulfurylisooximino acid derivative
07/24/2001US6265434 Antiinflammatory agents
07/24/2001US6265418 N-acylamino acid amide compounds and intermediates for preparation thereof
07/24/2001US6265417 Muscle relaxants
07/24/2001US6265410 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/24/2001CA2218503C Arylsulfonyl hydroxamic acid derivatives
07/24/2001CA2174033C Novel pyridine compounds; process for preparing the same and pharmaceutical compositions containing them
07/19/2001WO2001051493A1 Benzosulfones with calcium antagonist activity
07/19/2001WO2001051434A1 Reaction of carbonyl compounds with organometallic reagents
07/19/2001WO2001004090A3 Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods
07/19/2001US20010008903 Dioxinoindole and thienobenzodioxin compounds which are ht3 receptor antagonists and are used to treat central nervous system disorders
07/19/2001DE10001317A1 Reaction of carbonyl compound with organometallic reagent, e.g. preparation of biotin intermediate or 4-(4-(trans-4-pentylcyclohexyl) -1-cyclohexen-1-yl)-1-trifluoromethoxybenzene, uses mini- or microreactor
07/19/2001CA2396962A1 Benzosulfones and related compositions and methods
07/18/2001EP1116486A1 Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
07/18/2001EP1115710A1 Process for preparing regiospecific substituted pyrazine isomers
07/18/2001CN1304402A Sulfonamide derivatives
07/18/2001CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
07/17/2001US6262277 Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
07/17/2001US6262267 Has gonadotropin-releasing hormone antagonizing activity; useful for preventing or treating sex hormone-dependent diseases, e,g., sex hormone-dependent cancers e.g., prostatic cancer, uterine cancer, breast cancer, pituitary tumor
07/17/2001US6262257 Selective ion- and neutral molecule-binding agents forming supramolecular ensembles, and ion- and neutral molecule-separation agents
07/17/2001US6262060 Treatment of hyperglycaemia, diabetes, obesity or inflammation
07/17/2001US6262058 Pyrimidin-4-one derivatives as pesticide
07/17/2001US6262044 Modulators of protein tyrosine phosphatases (PTPASES)
07/17/2001US6262028 CONTAINING OXY-SUBSTITUTED AMIDINOBENZYL DERIVATIVES OF DIPEPTIDES FROM CYCLOHEXYLGLYCINE AND AZETIDINE-2-CARBOXYLIC ACID; ximelagatran
07/17/2001CA2160961C New tricyclic amide compounds, process for preparing the same and pharmaceutical compositions containing them
07/12/2001WO2001049682A1 Condensed azepines as vasopressin agonists
07/12/2001WO2001002370A9 Nickel-based reagents for detecting dna and dna-protein contacts
07/12/2001US20010007870 Compounds useful for inhibition of farnesyl protein transferase
07/12/2001US20010007869 Alpha-substittuted pyridazino quinoline compounds
07/12/2001US20010007867 Substituted 6,5-hetero-bicyclic derivatives
07/11/2001EP0801651B1 Hydroxymethylimidazodiazepines and their esters
07/11/2001CN1302804A Dihydrofuro [3,4-b] quinoline-1-ketone type compound, its preparation method and medicinal composition containing these compounds
07/10/2001US6258961 Intermediates and process for the preparation thereof
07/10/2001US6258948 An n-acylamino compound; antiinflammatory agents, autoimmune diseases
07/10/2001US6258807 Neuropathic pain and analgesics
07/10/2001US6258805 Pyrroloazepine derivatives
07/10/2001CA2175502C Cyclic amide derivatives
07/10/2001CA2059792C Tricyclic compounds and intermediates thereof
07/05/2001WO2001048039A2 Process for the preparation of ethylene polymers
07/05/2001WO2001047939A1 Heterocyclic metallocene compounds and use thereof in catalyst systems for producing olefin polymers
07/05/2001WO2001047933A1 New polymorphic forms of olanzapine
07/05/2001WO2001047919A1 Substituted oxazolidinones and their use in the field of blood coagulation
07/05/2001WO2001047892A1 Tricyclic protein kinase inhibitors
07/05/2001WO2001047883A1 Fused-ring compounds and use thereof as drugs
07/05/2001WO2001009094A3 Chemokine receptor antagonists and methods of use therefor
07/05/2001US20010006969 Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same
07/05/2001DE19962924A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use
07/05/2001CA2396579A1 Tricyclic protein kinase inhibitors
07/05/2001CA2363274A1 Fused-ring compounds and use thereof as drugs for hepatitis c
07/05/2001CA2363265A1 Heterocyclic metallocene compounds and use thereof in catalyst systems for producing olefin polymers
07/03/2001US6255490 Treating disorders associated with changes in cholinergic activity; non-opiate based analgesic for moderate to severe pain equally or exceeding the potency of opiate analgesics, yet lacking addictive side effects
07/03/2001US6255342 Pesticides
07/03/2001US6255318 Antiviral compounds
07/03/2001US6255310 Psychological disorders; antidepressants
07/03/2001CA2214005C Process and crystal forms of 2-methyl-thieno-benzodiazepine
07/03/2001CA2013516C Preparation process of new thieno-triazolo-diazepine
07/03/2001CA2006222C Enhanced chemiluminescence from 1,2-dioxetanes through energy transfer to tethered fluorescers
06/2001
06/28/2001WO2001046200A1 Novel piperidine and piperazine derivatives
06/28/2001WO2000077010A3 Substituted heterocycle fused gamma-carbolines
06/28/2001WO1999063937A9 Multivalent macrolide antibiotics
06/28/2001CA2394095A1 Novel piperidine and piperazine derivatives
06/27/2001EP1110964A1 Calixcrown derivatives for immobilizing proteins
06/27/2001EP1109815A1 Chemokine receptor antagonists and methods of use therefor
06/27/2001EP1109804A1 Chemokine receptor antagonists and methods of use therefor
06/27/2001EP1109802A1 Spirofluorenopyrans
06/27/2001EP1109796A1 Telomerase inhibitors and methods of their use
06/27/2001EP1109546A1 Ophthalmic compositions for treating ocular hypertension
06/27/2001CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors
06/27/2001CN1301156A Treatment of T-Helper cell tyre 2 mediated immune diseases with retinoid antagonists
06/27/2001CN1067686C Fused polycyclic heterocycle derivatives
06/27/2001CN1067685C Pyridazinoquinoline compounds